CoChat

Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12

Open access

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Hereditary spastic paraplegias (HSPs) are a group of genetically heterogeneous neurodegenerative conditions. They are characterized by progressive spastic paralysis of the legs as a result of selective, length-dependent degeneration of the axons of the corticospinal tract. Mutations in 3 genes encoding proteins that work together to shape the ER into sheets and tubules - receptor accessory protein 1 (REEP1), atlastin-1 (ATL1), and spastin (SPAST) - have been found to underlie many cases of HSP in Northern Europe and North America. Applying Sanger and exome sequencing, we have now identified 3 mutations in reticulon 2 (RTN2), which encodes a member of the reticulon family of prototypic ER-shaping proteins, in families with spastic paraplegia 12 (SPG12). These autosomal dominant mutations included a complete deletion of RTN2 and a frameshift mutation predicted to produce a highly truncated protein. Wild-type reticulon 2, but not the truncated protein potentially encoded by the frameshift allele, localized to the ER. RTN2 interacted with spastin, and this interaction required a hydrophobic region in spastin that is involved in ER localization and that is predicted to form a curvature-inducing/sensing hairpin loop domain. Our results directly implicate a reticulon protein in axonopathy, show that this protein participates in a network of interactions among HSP proteins involved in ER shaping, and further support the hypothesis that abnormal ER morphogenesis is a pathogenic mechanism in HSP.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci60560

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 197

Metadata

Authors
Montenegro, G., Rebelo, A. P., Connell, J., Allison, R., Babalini, C., D’Aloia, M., Montieri, P., Schüle, R., Ishiura, H., Price, J., Strickland, A., Gonzalez, M. A., Baumbach-Reardon, L., Deconinck, T., Huang, J., Bernardi, G., Vance, J. M., Rogers, M. T., Tsuji, S., De Jonghe, P., Pericak-Vance, M. A., Schöls, L., Orlacchio, A., Reid, E., & Züchner, S.
Affiliations
  • University of Miami (US)
  • University of Cambridge (GB)
  • Fondazione Santa Lucia (IT)
  • German Center for Neurodegenerative Diseases (DE)
  • The University of Tokyo (JP)
  • University of Antwerp (BE)
  • University of Rome Tor Vergata (IT)
  • University Hospital of Wales (GB)
Venue
Journal of Clinical Investigation
Published
2012-02-01
Volume
122
Issue
2
Pages
538-544
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2043714441
Cited by
170
References
26
Citations by year
2026: 6 · 2025: 8 · 2024: 11 · 2023: 12 · 2022: 12 · 2021: 12 · 2020: 10 · 2019: 13 · 2018: 9 · 2017: 12 · 2016: 9 · 2015: 9 · 2014: 17 · 2013: 16 · 2012: 13
FWCI
7.25
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • DZNE Pub (submittedVersion)
Funders
  • University of Miami
  • Wellcome Trust (082381, 079895)
  • Spastic Paraplegia Foundation
  • E-Rare
  • European Commission
  • Canada Excellence Research Chairs, Government of Canada
  • National Institutes of Health (079895)
  • Leonard M. Miller School of Medicine
  • Cambridge Institute for Medical Research, University of Cambridge (079895)
  • Japan Society for the Promotion of Science
  • National Institute of Neurological Disorders and Stroke (R01NS054132, R01NS072248)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords
axonopathy, spastin, frameshift mutation, protein truncation, spastic paraplegia, neurodegeneration, autosomal dominant inheritance
MeSH terms
Spastin, Adenosine Triphosphatases, DNA Mutational Analysis, Endoplasmic Reticulum, HeLa Cells, Humans, Membrane Proteins, Muscle Proteins, Mutation, Nerve Tissue Proteins, Spastic Paraplegia, Hereditary, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. https://app.cochat.ai/papers/10.1172/jci60560
The paper
Montenegro, G., Rebelo, A. P., Connell, J., Allison, R., Babalini, C., D’Aloia, M., Montieri, P., Schüle, R., Ishiura, H., Price, J., Strickland, A., Gonzalez, M. A., Baumbach-Reardon, L., Deconinck, T., Huang, J., Bernardi, G., Vance, J. M., Rogers, M. T., Tsuji, S., . . . Züchner, S. (2012). Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. Journal of Clinical Investigation. https://doi.org/10.1172/jci60560

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.